Ruben Abagyan
Affiliations: | Skaggs School of Pharmacy and Pharmaceutical Sciences | University of California, San Diego, La Jolla, CA |
Google:
"Ruben Abagyan"Children
Sign in to add traineeDik-Lung Ma | post-doc | UCSD (Chemistry Tree) | |
Juan Fernandez-Recio | post-doc | 1999-2003 | The Scripps Research Institute, California, USA |
Zhong-Ru (Paul) Xie | post-doc | 2012-2013 | UCSD |
Serge Batalov | research scientist | 1994-1999 | New York University School of Medicine (GenetiTree) |
Vsevolod Katritch | research scientist | 2003-2007 | University of California |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lebouvier N, Pagniez F, Na YM, et al. (2020) Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols. Pharmaceuticals (Basel, Switzerland). 13 |
Gu J, Huang Y, Yan Z, et al. (2020) Biomimetic Membrane-Structured Nanovesicles Carrying a Supramolecular Enzyme to Cure Lung Cancer. Acs Applied Materials & Interfaces |
Ngo T, Stephens BS, Gustavsson M, et al. (2020) Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity. Plos Biology. 18: e3000656 |
Nicola G, Kufareva I, Ilatovskiy AV, et al. (2020) Druggable exosites of the human kino-pocketome. Journal of Computer-Aided Molecular Design |
Kufareva I, Bestgen B, Brear P, et al. (2019) Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors. Scientific Reports. 9: 15893 |
Lam PC, Abagyan R, Totrov M. (2019) Macrocycle modeling in ICM: benchmarking and evaluation in D3R Grand Challenge 4. Journal of Computer-Aided Molecular Design |
Shi D, Chahal KK, Oto P, et al. (2019) Identification of four amoebicidal non-toxic compounds by a molecular docking screen of Naegleria fowleri sterol Δ8-Δ7-isomerase and phenotypic assays. Acs Infectious Diseases |
Bestgen B, Krimm I, Kufareva I, et al. (2019) 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. Part 1: Identification of an allosteric binding site. Journal of Medicinal Chemistry |
Bestgen B, Kufareva I, Seetoh W, et al. (2019) 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. Part 2: Structure-based optimization and investigation of effects specific to the allosteric mode of action. Journal of Medicinal Chemistry |
Chahal KK, Li J, Kufareva I, et al. (2019) Dynamic Structural Modeling Revealed That Nilotinib Inhibits Smoothened Signaling Neurosurgery. 66 |